{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:11:04Z","timestamp":1772539864508,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.7759\/cureus.63714","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T05:56:06Z","timestamp":1719986166000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Efficacy of Omalizumab in Severe Cedar Seasonal Allergic Rhinitis in Japan"],"prefix":"10.7759","author":[{"given":"Takakazu","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Amesara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Unno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20170278","article-title":"Cedar pollinosis and mortality: A population-based prospective cohort study in Japan","volume":"29","author":"Mori K","year":"2019","unstructured":"Mori K, Wada K, Konishi K, et al.. Cedar pollinosis and mortality: A population-based prospective cohort study in Japan. J Epidemiol. 2019, 29:61-4. 10.2188\/jea.JE20170278","journal-title":"J Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5631\/jibirin.114.837","article-title":"Drug selection from the perspective of lifestyle habits and patient questionnaire survey regarding second-generation antihistamines [Article in Japanese]","volume":"114","author":"Sato T","year":"2021","unstructured":"Sato T, Tareishi Y. Drug selection from the perspective of lifestyle habits and patient questionnaire survey regarding second-generation antihistamines [Article in Japanese]. Otolaryngol Clin. 2021, 114:837-43. 10.5631\/jibirin.114.837","journal-title":"Otolaryngol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.04.068","article-title":"Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: A randomized study","volume":"8","author":"Okubo K","year":"2020","unstructured":"Okubo K, Okano M, Sato N, Tamaki Y, Suzuki H, Uddin A, Fogel R. Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: A randomized study. J Allergy Clin Immunol Pract. 2020, 8:3130-3140. 10.1016\/j.jaip.2020.04.068","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22827","article-title":"Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice","volume":"11","author":"Hirano K","year":"2021","unstructured":"Hirano K, Suzaki I, Uruma S, et al.. Impact of omalizumab on pollen-induced seasonal allergic rhinitis: An observational study in clinical practice. Int Forum Allergy Rhinol. 2021, 11:1588-91. 10.1002\/alr.22827","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3950\/jibiinkotokeibu.125.5_884","article-title":"Clinical study of 20 cases of severe Japanese cedar pollen allergy treated with omalizumab [Article in Japanese]","volume":"125","author":"Kikkawa S","year":"2022","unstructured":"Kikkawa S, Minekawa A, Iesaka T, Hamajima T, Ishida K, Kitamura K. Clinical study of 20 cases of severe Japanese cedar pollen allergy treated with omalizumab [Article in Japanese]. Nippon Jibiinkoka Gakkai Kaiho. 2022, 125:884-91. 10.3950\/jibiinkotokeibu.125.5_884","journal-title":"Nippon Jibiinkoka Gakkai Kaiho"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.23.2956","article-title":"Effect of omalizumab on symptoms of seasonal allergic rhinitis: A randomized controlled trial","volume":"286","author":"Casale TB","year":"2001","unstructured":"Casale TB, Condemi J, LaForce C, et al.. Effect of omalizumab on symptoms of seasonal allergic rhinitis: A randomized controlled trial. JAMA. 2001, 286:2956-67. 10.1001\/jama.286.23.2956","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5631\/jibirin.115.765","article-title":"Clinical efficacy of 5 cases of seasonal cedar allergic rhinitis treated with omalizumab in 2020 and follow-up study in 2021 [Article in Japanese]","volume":"15","author":"Sato T","year":"20212022","unstructured":"Sato T, Ohta N, Shoji F, et al.. Clinical efficacy of 5 cases of seasonal cedar allergic rhinitis treated with omalizumab in 2020 and follow-up study in 2021 [Article in Japanese]. Otolaryngol Clin. 20212022, 15:765-9. 10.5631\/jibirin.115.765","journal-title":"Otolaryngol Clin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/00016489.2010.526961","article-title":"Quality of life of Japanese seasonal allergic rhinitis patients is related to timing of pollen dispersal - multicenter analysis","volume":"131","author":"Kanzaki S","year":"2011","unstructured":"Kanzaki S, Ogawa H, Ikeda M, Masuda T, Ogawa K. Quality of life of Japanese seasonal allergic rhinitis patients is related to timing of pollen dispersal - multicenter analysis. Acta Otolaryngol. 2011, 131:290-7. 10.3109\/00016489.2010.526961","journal-title":"Acta Otolaryngol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-200101000-00013","article-title":"The impact of allergies and allergy treatment on worker productivity","volume":"43","author":"Burton WN","year":"2001","unstructured":"Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med. 2001, 43:64-71. 10.1097\/00043764-200101000-00013","journal-title":"J Occup Environ Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7248\/jjrhi.49.481","article-title":"Japanese cedar pollinosis impact on work productivity, quality of life, and symptoms 2008 vs. 2009","volume":"49","author":"Minami Y","year":"2010","unstructured":"Minami Y, Shiozaki Y, Kato C, Ito M, Takeuchi N, Koyanagi M, Ogino S. Japanese cedar pollinosis impact on work productivity, quality of life, and symptoms 2008 vs. 2009. Japanese J Rhinol. 2010, 49:481-9. 10.7248\/jjrhi.49.481","journal-title":"Japanese J Rhinol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.06.021","article-title":"Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan","volume":"141","author":"Adachi M","year":"2018","unstructured":"Adachi M, Kozawa M, Yoshisue H, et al.. Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan. Respir Med. 2018, 141:56-63. 10.1016\/j.rmed.2018.06.021","journal-title":"Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.121949","article-title":"Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis","volume":"109","author":"Kuehr J","year":"2002","unstructured":"Kuehr J, Brauburger J, Zielen S, et al.. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol. 2002, 109:274-80. 10.1067\/mai.2002.121949","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3950\/JIBIINKOKA.124.748","article-title":"Efficacy of cedar sublingual immunotherapy in the third season: Comparison with subcutaneous immunotherapy [Article in Japanese]","volume":"124","author":"Noguchi N","year":"2021","unstructured":"Noguchi N, Ohta N, Yuta A, et al.. Efficacy of cedar sublingual immunotherapy in the third season: Comparison with subcutaneous immunotherapy [Article in Japanese]. J Otolaryngol Japan. 2021, 124:748-55. 10.3950\/JIBIINKOKA.124.748","journal-title":"J Otolaryngol Japan"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-015-9821-x","article-title":"Evaluation of IgE antibodies to omalizumab (Xolair\u00ae) and their potential correlation to anaphylaxis","volume":"18","author":"Baker DL","year":"2016","unstructured":"Baker DL, Nakamura GR, Lowman HB, Fischer SK. Evaluation of IgE antibodies to omalizumab (Xolair\u00ae) and their potential correlation to anaphylaxis. AAPS J. 2016, 18:115-23. 10.1208\/s12248-015-9821-x","journal-title":"AAPS J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70119-7","article-title":"A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray","volume":"98","author":"Graft D","year":"1996","unstructured":"Graft D, Aaronson D, Chervinsky P, et al.. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol. 1996, 98:724-31. 10.1016\/S0091-6749(96)70119-7","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266845-evaluating-the-efficacy-of-omalizumab-in-severe-cedar-seasonal-allergic-rhinitis-in-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T05:56:09Z","timestamp":1719986169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266845-evaluating-the-efficacy-of-omalizumab-in-severe-cedar-seasonal-allergic-rhinitis-in-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.63714","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}